188 related articles for article (PubMed ID: 30972077)
1. t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke.
Draxler DF; Lee F; Ho H; Keragala CB; Medcalf RL; Niego B
Front Immunol; 2019; 10():591. PubMed ID: 30972077
[No Abstract] [Full Text] [Related]
2. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.
Niego B; Broughton BRS; Ho H; Sobey CG; Medcalf RL
Fluids Barriers CNS; 2017 Nov; 14(1):33. PubMed ID: 29157263
[TBL] [Abstract][Full Text] [Related]
3. Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.
Suzuki Y; Nagai N; Umemura K; Collen D; Lijnen HR
J Thromb Haemost; 2007 Aug; 5(8):1732-9. PubMed ID: 17596135
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant.
Mei T; Kim A; Vong LB; Marushima A; Puentes S; Matsumaru Y; Matsumura A; Nagasaki Y
Biomaterials; 2019 Sep; 215():119209. PubMed ID: 31181394
[TBL] [Abstract][Full Text] [Related]
5. Early Recanalization Postintravenous Thrombolysis in Ischemic Stroke with Large Vessel Occlusion: A Digital Subtraction Angiography Study.
Mao YT; Mitchell P; Churilov L; Dowling R; Dong Q; Yan B
CNS Neurosci Ther; 2016 Aug; 22(8):643-7. PubMed ID: 27165451
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis.
Draxler DF; Daglas M; Fernando A; Hanafi G; McCutcheon F; Ho H; Galle A; Gregory J; Larsson P; Keragala C; Wright DK; Tavancheh E; Au AE; Niego B; Wilson K; Plebanski M; Sashindranath M; Medcalf RL
J Thromb Haemost; 2019 Dec; 17(12):2174-2187. PubMed ID: 31393041
[TBL] [Abstract][Full Text] [Related]
7. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
Ahn MY; Zhang ZG; Tsang W; Chopp M
Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
[TBL] [Abstract][Full Text] [Related]
8. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
[TBL] [Abstract][Full Text] [Related]
9. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic agents].
Nagao T
Nihon Rinsho; 2014 Jul; 72(7):1254-7. PubMed ID: 25163317
[TBL] [Abstract][Full Text] [Related]
11. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
[TBL] [Abstract][Full Text] [Related]
12. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
13. Recanalization therapies for acute ischemic stroke.
Broderick JP
Semin Neurol; 1998; 18(4):471-84. PubMed ID: 9932618
[TBL] [Abstract][Full Text] [Related]
14. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
[TBL] [Abstract][Full Text] [Related]
15. Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.
Zhu W; Libal NL; Casper A; Bodhankar S; Offner H; Alkayed NJ
Transl Stroke Res; 2014 Oct; 5(5):612-7. PubMed ID: 24953050
[TBL] [Abstract][Full Text] [Related]
16. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
Nicolini FA; Nichols WW; Saldeen TG; Mehta JL
Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
[TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities.
Röther J; Ford GA; Thijs VN
Cerebrovasc Dis; 2013; 35(4):313-9. PubMed ID: 23615379
[TBL] [Abstract][Full Text] [Related]
19. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.
Suzuki Y; Nagai N; Umemura K
J Pharmacol Sci; 2011; 116(1):25-9. PubMed ID: 21498957
[TBL] [Abstract][Full Text] [Related]
20. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion.
Miyazaki T; Kimura Y; Ohata H; Hashimoto T; Shibata K; Hasumi K; Honda K
Stroke; 2011 Apr; 42(4):1097-104. PubMed ID: 21350203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
